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Abstract
Neutrophils are essential innate immune cells whose responses are crucial in the clearance
of invading pathogens. Neutrophils can respond to infection by releasing neutrophil extra-
cellular traps (NETs). NETs are formed of chromatin and specific granular proteins and are
released after execution of a poorly characterized cell death pathway. Here, we show that
NET formation induced by PMA or Candida albicans is independent of RNA polymerase II
and III-mediated transcription as well as of protein synthesis. Thus, neutrophils contain all
the factors required for NET formation when they emerge from the bone marrow as differen-
tiated cells.
Introduction
Neutrophils (also called polymorphonuclear leukocytes, PMNs) are essential for innate
immune defense because they are directly antimicrobial and can shape adaptive immunity [1,
2]. Neutropenic individuals are prone to infections, underscoring the key role of neutrophils in
fighting pathogens. PMNs differentiate in the bone marrow and are released in high numbers
into the circulation as terminally differentiated cells. During infections neutrophils are rapidly
recruited to inflammatory sites where they activate different antimicrobial programs, such as
phagocytosis, production of reactive oxygen species (ROS), degranulation or the formation of
neutrophil extracellular traps (NETs). NETs are released by PMNs after the activation of a spe-
cialized cell death pathway and consist of chromatin bound to cytoplasmic proteins [3, 4, 5].
Microorganisms as well as chemical compounds trigger NET formation, however, the molecu-
lar mechanism leading to release of NETs is only poorly characterized. Many NET inducers
trigger MAP kinase signaling [6], activate NADPH oxidase (Nox2) and involve the subsequent
production of ROS. This leads to granule rupture mediated by a protein complex called “azuro-
some”, translocation of neutrophil elastase (NE) to the nucleus, chromatin decondensation
and NET production [7]. NETs sequester and immobilize pathogenic organisms, thus contrib-
uting to immune defense. Furthermore, NETs are dyresgulated in several auto-immune and
inflammatory diseases, making them an important target for potential therapeutic interven-
tions [5].
Most proteins required for neutrophil antimicrobial activity are transiently synthesized dur-
ing development and packed in specialized granules that are deployed upon PMN activation.
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Indeed, essential neutrophil antimicrobial defense proteins like NE, Proteinase 3, Cathepsin G
or Myeloperoxidase (MPO) are only produced during a neutrophil precursor stage and not in
circulating cells [8]. Despite this, PMNs respond to bacteria by markedly changing gene expres-
sion patterns [9]. Most prominently, they produce chemokines like Interleukin (IL)-8 or Mac-
rophage Inflammatory Protein (Mip) -1α. Furthermore, the MAP kinase pathways, which are
known to be essential for NET induction, can also induce transcription. We therefore tested
whether transcription or translation are required for NET formation.
Materials and Methods
Inhibitors
Actinomycin D (Sigma), flavopiridol (Enzo Life Sciences), CAS 577784-91-9 (Merck Milli-
pore), cycloheximide (Sigma)
Isolation and stimulation of human neutrophils
Neutrophils were isolated from blood of healthy volunteers and according to the Declaration
of Helsinki. Study participants provided written informed consent. All samples were collected
with approval from the ethics committee–Charité –Universitätsmedizin Berlin. After centrifu-
gation over Histopaque-1119 (Sigma), neutrophils were purified over a discontinuous Percoll
gradient [4]. Experiments were performed in RPMI-1640 (w/o phenol red) supplemented with
10 mMHEPES and 0.2% human serum albumin. Cells were seeded at 105/well (96 well plate)
for Mip-1α ELISA or 2x105/well (24 well plate) for NET experiments and incubated with tran-
scription/ translation inhibitors for 5 min before treatment with LPS (1 g/ ml, from Salmonella
typhimurium (Enzo)), PMA (100 nM) or infection with Candida albicans hyphae (opsonized
with 10% human serum, 30min at 37°C, before infection).
Isolation and stimulation of murine neutrophils
Mouse breeding and experiments were approved by the Berlin state authority Landesamt für
Gesundheit und Soziales. All animals were locally bred at the Max Planck Institute for Infection
Biology. Animals were housed in approved specific pathogen free (SPF) conditions, maintained
on a 12 hour light/dark cycle and fed ad libitum. Precautions were taken to minimize suffering
of the animals. We used male mice that were 8–12 weeks of age. Group size was n = 3. Mice
were sacrificed by cervical dislocation the night before the experiment and tibias and femurs
were stored at 4°C overnight. Neutrophils were purified from bone marrow by negative selec-
tion using EasySep™Mouse Neutrophil Enrichment Kit (Stemcell Technologies). NETs were
induced by plating 105 cells in tissue culture plates (24 wells) in RPMI-1640 supplemented
with 10 mMHepes, 2% mouse serum (Dnase -/-) and 100 ng/ml murine GCSF. Stimulation
was with PMA (100 nM) or heat killed C. albicans at a MOI of 3, both for 15 hours. C.albicans
yeast were grown for 3h at 37°C to induce hyphal growth, followed by 1h incubation at 65°C
for heat inactivation. Cytokine production was assayed in RPMI-1640 supplemented with 10%
FCS after activation with 200 ng/ml LPS.
ELISA/ LDH
Human and mouse Mip-1α levels in culture supernatants were determined using BD DuoSet
ELISA kit (R&D). LDH release was quantified from the same supernatants by Cytotox 96 Non-
Radioactive Cytotoxicity Assay (Promega).
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Immunofluorescence microscopy
Cells were fixed with 2% paraformaldehyde (PFA) and processed as previously reported [10].
NETs were detected with mouse mAB PL2-3, directed against the subnucleosomal complex of
Histone 2A, Histone 2B, and chromatin [11] and an anti-NE antibody (Calbiochem). Hoechst
or DAPI were used to counterstain DNA. Image acquisition was on a Leica DMR upright fluo-
rescence microscope equipped with a Jenoptic B/W digital microscope camera.
NET quantification
NETs were enumerated using three different techniques: 1. a SYTO/SYTOX staining tech-
nique. The cell impermeable SYTOX orange dye (1 μM) was used to detect NETs. SYTO green,
a cell-permeable DNA dye (250 nM), was used to determine the total number of cells. Images
were taken on a Leica DM IRBE inverted microscope. 2. Immunofluorescence staining as
described above, followed by automated quantification of NETs using ImageJ. The Hoechst sig-
nal was used to calculate the total amount of cells per microscopic field and NETs were quanti-
fied by the PL2-3 signal (chromatin) accounted for nuclear expansion [10]. 3. By using the cell
impermeable DNA dye SYTOX green (50 nM) and measuring in a fluorometer with an excita-
tion/ emission of 485/518 nm, respectively.
Quantitative real time PCR
RNA was isolated using RNeasy mini kit (Qiagen) and cDNA was synthetized with the High-
capacity RNA-to-cDNA kit (Applied Biosystems) according to manufacturer’s protocol. Real-
time PCR was performed on StepOnePlus Real-Time PCR System with 2x Fast SYBR Green
master mix (Applied Biosystems). Previously verified primers [12] were used for MIP-1α: F
5’-AGCTGACTACTTTGAGACGAGCA-3’ and R 5’-CGGCTTCGCTTGGTTAGGA-3’, and
the housekeeping gene β2-microglobulin: F 5’-CTCCGTGGCCTTAGCTGTG-3’ and R 5’-TT
TGGAGTACGCTGGATAGCCT-3’. Standard curves were used to establish amplification
products. Data were analyzed using StepOne software and expressed as relative amount of
MIP1-α product divided by relative amount of β2- microglobulin product for each treatment.
Statistical Analysis
Statistical significance was determined using one way analysis of variance (ANOVA) with mul-
tiple comparison, comparing all inhibitor treatments to DMSO. An exception is Fig 1E, where
an unpaired T test was used, comparing DMSO to flavopiridol treatment. A statistically signifi-
cant result was considered to be p<0.05. Raw values from individual donors and mice for all
cytokine and NET quantifications are included as supplementary excel files (S1 Table and
S2 Table).
Fig 1. Human neutrophils do not require transcription or translation to release NETs in response to PMA. (A-G).
Inhibitors were used at the following concentrations: Actinomycin D (1 μg/ ml), flavopiridol (0.05 μM), CAS 577784-91-9
(10 μM), CHX (1 μg/ ml). (A) Actinomycin D, flavopiridol and CHX, but not CAS 577784-91-9 inhibit de novo production of
Mip-1α induced by LPS. (B) Actinomycin D and flavopiridol, but not CAS 577784-91-9or CHX block mRNA transcription of
PMA-treated human neutrophils. (C.) Actinomycin D, flavopiridol and CHX, but not CAS 577784-91-9 inhibit de novo
production of IL-8 induced by PMA. (D-G) Actinomycin D, flavopiridol, CAS 577784-91-9 or CHX do not block NET formation
in response to PMA (100 nM). (D, E). NET formation was quantified by adding the DNA dye SYTO green (total cells) and the
cell impermeable DNA dye SYTOX orange (NETs). (F) NET formation was quantified by immunofluorescence staining of
chromatin and Hoechst as previously described [10]. Graphs showmean ± SEM from independent experiments with at least
3 different donors. (G) Representative images of human neutrophils stained with PL2-3 (chromatin, red), NE (Neutrophil
Elastase, green) and Hoechst (blue) after treatment with transcription or translation inhibitors and PMA induction. (D-F)
Statistical analysis revealed no significant changes after inhibitor treatment.
doi:10.1371/journal.pone.0157454.g001
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Results
To investigate the requirement of transcription or translation for NET formation, we treated
human primary neutrophils with the RNA polymerase II inhibitors actinomycin D and flavo-
piridol, the RNA polymerase III inhibitor CAS 577784-91-9 and the translation inhibitor
cycloheximide (CHX). We first confirmed the activity of our inhibitors and titrated the mini-
mal concentrations required for inhibition in neutrophils. To accomplish this we used as our
readout the transcription and translation of Mip-1α, a chemokine known to be produced de
novo in response to LPS [13] (Fig 1A, S1A Fig). Both RNA polymerase II inhibitors as well as
CHX efficiently blocked de novo production of Mip-1α in a dose-dependent manner (S1A Fig).
As expected, inhibition of RNA polymerase III did not influence Mip-1α production (Fig 1A,
S1A Fig). None of the inhibitors were toxic to PMNs at the concentrations used (Fig 1D and
1E, S1B Fig). We next used the same readout with PMA, the stimulus to be used in NET induc-
tion, to validate the inhibitory concentrations. Upon PMA treatment, neutrophils induced
transcription of Mip-1αmRNA, which was blocked by addition of both actinomycin D and fla-
vopiridol (Fig 1B). When we analyzed production of Mip-1α at the protein level, we were not
able to detect any protein after PMA treatment (data not shown). However, PMA treatment of
neutrophils led to de novo synthesis of the chemokine IL-8, which was inhibited by actinomy-
cin D, flavopiridol and CHX (Fig 1C). These data demonstrate that all inhibitors were able to
efficiently block de novo gene expression in PMA-treated neutrophils.
We then investigated whether inhibition of transcription or translation affected NET forma-
tion of PMA-treated neutrophils. We quantified NET formation with three different methods
and found that inhibition of transcription or translation had no impact on NET formation
upon PMA induction (Fig 1D–1G, S2A Fig). Addition of actinomycin D and CHX together
showed an additive effect on the inhibition of IL-8 production (Fig 1C). Therefore we also
treated neutrophils with combinations of inhibitors before PMA treatment. Again, we found
no effect on NET formation (Fig 1F, S2C Fig). These data show that human neutrophils do not
require de novo gene expression to make NETs in response to PMA.
We also analyzed the involvement of transcription and translation in NET formation
induced by the fungal pathogen Candida albicans. Similarly to PMA treatment, infection of
human neutrophils with C. albicans induced the formation of NETs, which occurred indepen-
dently of transcription and translation (Fig 2A, S2B Fig). Importantly, irrespective of inhibitor
treatment, all cells proceeded from early stages of NETosis with decondensed chromatin (Fig
2B) to fully spread NETs (Fig 2C), again demonstrating that transcription or translation inhibi-
tors were not able to block NET formation.
We then tested an involvement of transcription and translation in murine neutrophils puri-
fied from bone marrow. The RNA polymerase II inhibitor flavopiridol as well as CHX blocked
production of Mip-1α efficiently (Fig 3A, S1C Fig). Importantly, inhibition of neither RNA poly-
merase II, RNA polymerase III nor protein synthesis had an impact on NET formation in
Fig 2. Human neutrophils do not require transcription or translation to release NETs in response toC.
albicans. (A, B) Inhibitors were used at the following concentrations: Actinomycin D (1 μg/ ml), flavopiridol
(0.05 μM), CAS 577784-91-9 (10 μM), CHX (1 μg/ ml). Cells were infected with opsonizedC.albicans at MOI
5 and subsequently fixed for immunofluorescence staining. (A) NET formation was quantified at 2h after
infection by immunofluorescence staining of chromatin and Hoechst. Graphs showmean ± SEM from
independent experiments with 3 different donors. (B) Representative images of an early time point (2h) of
human neutrophils infected withC.albicans and treated with transcription or translation inhibitors. Cells were
stained with PL2-3 (chromatin, red), NE (Neutrophil elastase, green) and Hoechst (blue). (C) Representative
images of a late time point (4h) of C.albicans-infected neutrophils showing spread NETs that are unaffected
by inhibitors of gene expression. (A) Statistical analysis revealed no significant changes after inhibitor
treatment.
doi:10.1371/journal.pone.0157454.g002
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Fig 3. Mouse neutrophils do not require transcription or translation to release NETs. Inhibitors were used at the following concentrations: Flavopiridol
(0.05 μM), CAS 577784-91-9 (10 μM), CHX (1 μg/ ml). (A) Flavopiridol and CHX, but not CAS 577784-91-9 block Mip-1α production in response to LPS. (B)
PMA-induced NET formation is not inhibited by flavopiridol, CAS 577784-91-9 or CHX. Neutrophils isolated from Nox2 -/-mice are used as negative control.
(C) NET formation in response to heat-killedC. albicans is not blocked by inhibitors. Graphs showmean ± SEM of experiments with neutrophils isolated from
3 mice. (D) Representative immunofluorescence pictures of murine neutrophils stained with PL2-3 (chromatin, red) and DAPI (blue) after infection withC.
albicans (MOI 3) and treatment with transcription/ translation inhibitors. (B, C) Statistical analysis revealed no significant changes after inhibitor treatment.
doi:10.1371/journal.pone.0157454.g003
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response to PMA (Fig 3B) or to C. albicans (Fig 3C and 3D). As previously shown [14], Nox2 -/-
neutrophils failed to produce NETs to either stimuli (Fig 3C and 3D) and are here used as a con-
trol. Taken together these data demonstrate that NET formation of both murine and human neu-
trophils occurs independently of de novo gene expression and thus relies on proteins already
existing in neutrophils.
Discussion
In line with previously published findings that LPS-induced NETs don't require protein trans-
lation for their formation [15], we demonstrate that PMA- and C.albicans-induced NETs pro-
ceed independently of translation. Importantly, we also demonstrate that transcriptional
responses are dispensable for NET formation of human and murine neutrophils. Despite the
demonstrated efficiency of actinomycin D, flavopiridol and CHX, the possibility remained that
minute amounts of de novo produced mRNA or protein contribute to NETosis. However,
treatment with combinations of inhibitors did not block NET formation either, although they
had an additive effect on blocking chemokine production. We therefore conclude that PMA-
and C.albicans-induced NETosis indeed occur independently of de novo gene expression.
Notably, human and murine NETs are morphologically distinct; human NETs are spread
out, especially after infection with C. albicans, whereas murine NETs are compact and less dif-
fuse. This makes it challenging to accurately quantify human C.albicans-induced NETs We
thus employed two different quantification approaches. The use of a cell impermeable DNA
dye has limitations since the fluorometer readout does not discriminate between different
forms of cell death. However, it showed that the overall response to C.albicans infection was
similar in all settings tested. Furthermore, quantification by immunofluorescence staining and
analyzing NETs by using an anti-chromatin antibody confirmed that also C.albicans-induced
NETs didn’t require transcription or translation. This finding is important since C.albicans
infection is a more physiological trigger of NET formation than PMA.
NET formation can be induced by various stimuli and, although it might be executed via
different pathways, it is also accompanied by induction of transcription. Indeed, MAPK signal-
ing is essential for NET formation and also for the activation of the complex transcriptional
program of neutrophils. Importantly, here we described that NETs are formed independently
of macromolecular synthesis. Neutrophil activation thus involves parallel pathways: one that
relies on transcription to produce chemokines and to amplify the inflammatory response, and
a second, transcription-independent one that results in NETs and other antimicrobial effects.
Supporting Information
S1 Fig. Inhibitor titration. (A, B) Increasing doses of inhibitors were added to human neutro-
phils before LPS stimulation. Actinomycin D: 0.01 μg/ ml; 0.1 μg/ ml; 1 μg/ ml; 5 μg/ ml, flavo-
piridol: 0.02 μM; 0.05 μM; 1 μM, CAS 577784-91-9: 0.1 μM; 1 μM; 10 μM; 50 μM, CHX: 0.1 μg/
ml; 1 μg/ ml; 10 μg/ ml; 100 μg/ ml. Minimal inhibitor concentrations used for NET experi-
ments are shown in blue. (A) The efficiency of inhibitors was analyzed in human primary neu-
trophils by measuring their effect on de novo production of Mip-1α in response to LPS
stimulation (1 μg/ ml) for 20h. (B) The toxicity of inhibitors was monitored by measuring
LDH release after 20h of LPS treatment. Graphs show mean ± SEM of independent experi-
ments with 3 different donors. (C) Increasing doses of inhibitors were added to murine neutro-
phils before stimulation with LPS. Flavopiridol: 0.025 μM; 0.05 μM; 0.1 μM; 0.2 μM; 1μM, CAS
577784-91-9: 1 μM, CHX: 0.5 μg/ ml; 1 μg/ ml; 5 μg/ ml. Minimal concentrations blocking pro-
duction of Mip-1α and subsequently used for NET experiments are shown in blue. Efficiency
of inhibitors was analyzed by measuring production of Mip-1α in response to LPS stimulation
NETs Do Not Require De NovoGene Expression
PLOS ONE | DOI:10.1371/journal.pone.0157454 June 16, 2016 8 / 10
(200 ng/ ml) for 20h.
(EPS)
S2 Fig. No effect of individual or combined inhibitors on NET formation. Inhibitors were
used at the following concentrations: Actinomycin D (1 μg/ ml), flavopiridol (0.05 μM), CAS
577784-91-9 (10 μM), CHX (1 μg/ ml). (A, B) Human primary neutrophils were treated with
transcription/ translation inhibitors as indicated. (A) After inhibitor treatment, cells were
treated with 50 nM SYTOX green, stimulated with 100 nM PMA and analyzed by measuring
emission of SYTOX green every hour in a fluorometer. (B) After inhibitor treatment, neutro-
phils were treated with 50 nM SYTOX green and infected with opsonized C.albicans at MOI 5.
SYTOX emission was measured every hour in a fluorometer. (C) Representative immunofluo-
rescence pictures of human primary neutrophils treated with combinations of transcription/
translation inhibitors as indicated and stimulated with 100 nM PMA. Cells were stained with
PL2-3 (chromatin, red), NE (Neutrophil elastase, green) and Hoechst (blue). (D) Representa-
tive pictures of SYTO green/ SYTOX orange assay in human primary neutrophils stimulated
with C.albicans (MOI 5). SYTO green stains all cells, SYTOX orange stains dead cells and
extracellular traps.
(EPS)
S1 Table. Numerical values used for quantification.
(XLSX)
S2 Table. Numerical values used for quantification of supplementary data.
(XLSX)
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